Attentin 20 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

attentin 20 mg tablett

medice arzneimittel pütter gmbh & co. kg - dexamfetaminsulfat - tablett - 20 mg - isomalt hjälpämne; dexamfetaminsulfat 20 mg aktiv substans

Attentin 10 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

attentin 10 mg tablett

medice arzneimittel pütter gmbh & co. kg - dexamfetaminsulfat - tablett - 10 mg - isomalt hjälpämne; dexamfetaminsulfat 10 mg aktiv substans

Acetylsalicylsyra Aristo 100 mg Enterotablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

acetylsalicylsyra aristo 100 mg enterotablett

aristo pharma gmbh - acetylsalicylsyra - enterotablett - 100 mg - acetylsalicylsyra 100 mg aktiv substans; laktosmonohydrat hjälpämne

Acetylsalicylsyra Aristo 75 mg Enterotablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

acetylsalicylsyra aristo 75 mg enterotablett

aristo pharma gmbh - acetylsalicylsyra - enterotablett - 75 mg - acetylsalicylsyra 75 mg aktiv substans; laktosmonohydrat hjälpämne; para-orange aluminiumlack hjälpämne

Ranivisio Europeiska unionen - svenska - EMA (European Medicines Agency)

ranivisio

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ögonsjukdomar - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Oxycodone/Naloxone Glenmark 10 mg/5 mg Depottablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

oxycodone/naloxone glenmark 10 mg/5 mg depottablett

glenmark arzneimittel gmbh - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 10 mg/5 mg - laktosmonohydrat hjälpämne; stearylalkohol hjälpämne; naloxonhydrokloriddihydrat 5,5 mg aktiv substans; oxikodonhydroklorid 10 mg aktiv substans

Oxycodone/Naloxone Glenmark 5 mg/2,5 mg Depottablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

oxycodone/naloxone glenmark 5 mg/2,5 mg depottablett

glenmark arzneimittel gmbh - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 5 mg/2,5 mg - laktosmonohydrat hjälpämne; stearylalkohol hjälpämne; naloxonhydrokloriddihydrat 2,75 mg aktiv substans; oxikodonhydroklorid 5 mg aktiv substans

Oxycodone/Naloxone Glenmark 20 mg/10 mg Depottablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

oxycodone/naloxone glenmark 20 mg/10 mg depottablett

glenmark arzneimittel gmbh - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 20 mg/10 mg - stearylalkohol hjälpämne; oxikodonhydroklorid 20 mg aktiv substans; naloxonhydrokloriddihydrat 11 mg aktiv substans

Oxycodone/Naloxone Glenmark 40 mg/20 mg Depottablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

oxycodone/naloxone glenmark 40 mg/20 mg depottablett

glenmark arzneimittel gmbh - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 40 mg/20 mg - stearylalkohol hjälpämne; naloxonhydrokloriddihydrat 22 mg aktiv substans; oxikodonhydroklorid 40 mg aktiv substans

Adakveo Europeiska unionen - svenska - EMA (European Medicines Agency)

adakveo

novartis europharm limited - crizanlizumab - anemi, sickle cell - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.